Atrial Fibrillation Screening and Education Study

NCT03440762 | Completed

• 1 other identifier: 17-005031
• Study Type: interventional
• Target: 83
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate the outcomes of a community placed atrial fibrillation (AF) screening and education program

Conditions

Atrial Fibrillation

Keywords

Screening; Education; AFib Awareness; Stroke prevention

Outcome Measures

Primary Outcomes (3)

• Feasibility-number enrolled

  number of participants enrolled

  5 months

• Feasibility-time required for study procedure

  Number of minutes require to perform mobile ECG

  5 months

• Participants' perception of the usefulness of the Learning Station activities

  The outcome will be measured by the Participant Perception of Learning Station Activities survey. This survey is an investigator developed 9-item Survey that asks participants to rate how useful learning activities were to increase their knowledge about atrial fibrillation and to what extent their knowledge about atrial fibrillation has increased after participating in the Learning Station activities. Psychometric testing has not been performed on this survey.

  5 months

Secondary Outcomes (2)

• Change in knowledge attitude, and beliefs scores about AF self monitoring from baseline

  5 months

• Number of cases of atrial fibrillation detected with portable ECG

  5 months

Study Arms (1)

AF awareness education

OTHER

AF awareness education face to face

Behavioral: AF awareness education

Interventions

AF awareness education BEHAVIORAL

Participants will receive education about a description of AF, complications, recognition of signs and symptoms of AF, pulse taking, and how to recognize an irregular pulse

AF awareness education

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

Inclusion : Any two of the following: * Hypertension * Diabetes * Sleep apnea * Obesity * Age \> 75 years * Peripheral arterial disease * Female Exclusion : * Previous diagnosis of atrial fibrillation or atrial flutter * Uncompensated visual impairment * Uncompensated hearing impairment * Inability to communicate verbally in English

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Mayo Clinic: lead
• Heart Rhythm Society: collaborator

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Pamela J McCabe

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Nurse Scientist

Model Details: Single group pre-post educational intervention

Study Record Dates

• First Submitted: February 1, 2018
• First Posted: February 22, 2018
• Study Start: August 16, 2017
• Primary Completion: February 28, 2018
• Study Completion: August 27, 2019
• Last Updated: September 14, 2020

Record last verified: 2020-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)